| Details |
title |
year |
| Details |
AND ADHD: DOSE EFFECTS ON ADHD SYMPTOMS AND FUNCTIONING... |
2017 |
| Details |
CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER... |
2017 |
| Details |
W3. ANXIETY AS A CONFOUNDING SYMPTOM IN ADHD TRIALS... |
2017 |
| Details |
DISORDER (ADHD)... |
2017 |
| Details |
TRIAL OF THE MIXED OPIOID RECEPTOR ANTAGONIST NALTREXONE... |
2017 |
| Details |
DEPENDENT SUBJECTS ON BUPRENORPHINE... |
2017 |
| Details |
OPIOID-DEPENDENT SUBJECTS... |
2017 |
| Details |
A CRITICAL REGION FOR SEX DIFFERENCES IN REWARD... |
2017 |
| Details |
ROAD TO A BETTER PHENOTYPIC CHARACTERIZATION?... |
2017 |
| Details |
STIMULANT USE DISORDER... |
2017 |
| Details |
BAC AND SELF-REPORT STANDARDS FOR HEAVY DRINKING... |
2017 |
| Details |
GENERALIZED ANXIETY DISORDER... |
2017 |
| Details |
AN ANALYSIS OF SECONDARY OUTCOME MEASURES... |
2017 |
| Details |
KETAMINE IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION... |
2017 |
| Details |
WITH BIPOLAR DISORDER... |
2017 |
| Details |
RANDOMIZED WITHDRAWAL STUDY... |
2017 |
| Details |
RECURRENCE AND ON RECOVERY... |
2017 |
| Details |
DIAGNOSIS IN CHILDREN AND ADOLESCENTS... |
2017 |
| Details |
CLINICAL PRACTICE?... |
2017 |
| Details |
USE IN SCREENING FOR MCI DUE TO AD... |
2017 |